通过基于COI1的虚拟查来设计,合成和系统性获得的2-二甲基亚醇基诺林-4-碳胺的耐药性
Xiaoyu Liu1,2, Hongwei Yang1,2, Yaru Sun1,2
1State Key Laboratory of Elemento-Organic Chemistry, College of Chemistry, Nankai University, No. 94, Weijin Road, Tianjin, 300071, People's Republic of China.
Molecular diversity
|April 28, 2024
概括
研究人员通过准冠状素不敏感的1 (COI1) 来确定了新型植物诱导因子的,即2-二甲二基诺林-4-碳胺. 这些化合物在活体中显示出Arabidopsis thaliana对菌的显著系统性获得耐药性.
科学领域:
- 植物病理学 植物病理学
- 药品化学 药品化学 是一个
- 分子生物学分子生物学
背景情况:
- 冠状腺素不敏感的1 (COI1) 是已知的植物诱导体冠状腺素 (COR) 的受体.
- 发现新的植物诱导因子对于作物保护战略至关重要.
研究的目的:
- 通过针对COI1.1来识别新型植物诱导因子的潜在客户.
- 根据虚拟选结果设计和合成2-甲亚醇-4-碳胺基.
- 为了评估合成化合物的生物活性.
主要方法:
- 从ZINC数据库中对129种化合物的虚拟选,使用对COI1.1进行对接.
- 合理的设计和化学合成的2-二甲醇基诺林-4-碳胺.
- 在体外抗真菌活性测定.
- 在Arabidopsis thaliana对Hyaloperonospora arabidopsidis进行体内系统性获得耐药性 (SAR) 测定.
主要成果:
- 虚拟选确定了氨酸胺作为潜在的COI1向分子.
- 没有一种合成的化合物在体外表现出显著的抗真菌活性.
- 化合物4d,4e和4o在50μM度的活体SAR试验中显示出超过80%的抑制率.
- 这些化合物赋予了Arabidopsis thaliana对Hyaloperonospora arabidopsidis的耐药性.
结论:
- 2-二二二醇基诺林-4-碳胺是新型植物诱导因子的有希望的来源.
- 需要进一步的研究来探索它们在作物保护方面的潜力.
- 已识别的化合物调节植物防御机制.
关键词:
西二二醇的使用方法在COI1中,COI1是COI1的前身,COI1是COI1.分子设计分子设计.植物诱导者 植物诱导者奎诺林 (quinoline) 是一种氨酸.综合合成 综合合成系统性获得的阻力活动.虚拟选是一个虚拟的选.更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
992
05:59Author Spotlight: Advancing Antimicrobial Resistance Research with Innovative Approaches and Synthetic Compounds
Published on: September 27, 2024
2.0K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
01:26Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K